Stephan Harbarth
In-hospital outcomes of healthcare-associated COVID-19 (Omicron) versus healthcare-associated influenza: a retrospective, nationwide cohort study in Switzerland.
Grant R, van Linde M, Buetti N, Jackson H, Abbas M, Sobel J, Sommerstein R, Eder M, Balmelli C, Troillet N, Schreiber P, Jent P, Senn L, Flury D, Tschudin-Sutter S, Buettcher M, Süveges M, Urbini L, Keiser O, Roder U, Harbarth S, Zanella M, CH-SUR study group. In-hospital outcomes of healthcare-associated COVID-19 (Omicron) versus healthcare-associated influenza: a retrospective, nationwide cohort study in Switzerland. Clin Infect Dis 2024
13.11.2024In-hospital outcomes of healthcare-associated COVID-19 (Omicron) versus healthcare-associated influenza: a retrospective, nationwide cohort study in Switzerland.
13.11.2024Clin Infect Dis 2024
Grant Rebecca, van Linde Myra E, Buetti Niccolo, Jackson Holly, Abbas Mohamed, Sobel Jonathan Aryeh, Sommerstein Rami, Eder Marcus, Balmelli Carlo, Troillet Nicolas, Schreiber Peter W, Jent Philipp, Senn Laurence, Flury Domenica, Tschudin-Sutter Sarah, Buettcher Michael, Süveges Maria, Urbini Laura, Keiser Olivia, Roder Ursina, Harbarth Stephan, Zanella Marie-Céline, CH-SUR study group
Regional spread of an atypical ESBL-producing ST131H89 clone among different human and environmental reservoirs in Western Switzerland.
Martischang R, Seth-Smith H, Verschuuren T, Héquet D, Gaïa N, François P, Fluit A, Earnshaw J, Seiffert S, Tacconelli E, Cherkaoui A, Harbarth S, Egli A, Kohler P. Regional spread of an atypical ESBL-producing ST131H89 clone among different human and environmental reservoirs in Western Switzerland. Antimicrob Agents Chemother 2024:e0092523.
03.01.2024Regional spread of an atypical ESBL-producing ST131H89 clone among different human and environmental reservoirs in Western Switzerland.
03.01.2024Antimicrob Agents Chemother 2024:e0092523
Martischang Romain, Seth-Smith Helena M B, Verschuuren Tess D, Héquet Delphine, Gaïa Nadia, François Patrice, Fluit Ad C, Earnshaw J J, Seiffert Salome N, Tacconelli Evelina, Cherkaoui Abdessalam, Harbarth Stephan, Egli Adrian, Kohler Philipp
Timing of Cefuroxime Surgical Antimicrobial Prophylaxis and Its Association With Surgical Site Infections.
Sommerstein R, Troillet N, Harbarth S, van Linde M, Vuichard-Gysin D, Kuster S, Widmer A, Swissnoso group. Timing of Cefuroxime Surgical Antimicrobial Prophylaxis and Its Association With Surgical Site Infections. JAMA Netw Open 2023; 6:e2317370.
01.06.2023Timing of Cefuroxime Surgical Antimicrobial Prophylaxis and Its Association With Surgical Site Infections.
01.06.2023JAMA Netw Open 2023; 6:e2317370
Sommerstein Rami, Troillet Nicolas, Harbarth Stephan, van Linde Myra E, Vuichard-Gysin Danielle, Kuster Stefan, Widmer Andreas F, Swissnoso group
Providing care to patients in contact isolation: is the systematic use of gloves still indicated?
Bellini C, Eder M, Senn L, Sommerstein R, Vuichard-Gysin D, Schmiedel Y, Schlegel M, Harbarth S, Troillet N. Providing care to patients in contact isolation: is the systematic use of gloves still indicated?. Swiss Med Wkly 2022; 152:w30110.
07.02.2022Providing care to patients in contact isolation: is the systematic use of gloves still indicated?
07.02.2022Swiss Med Wkly 2022; 152:w30110
Bellini Cristina, Eder Marcus, Senn Laurence, Sommerstein Rami, Vuichard-Gysin Danielle, Schmiedel Yvonne, Schlegel Matthias, Harbarth Stephan, Troillet Nicolas
High adherence to national IPC guidelines as key to sustainable VRE control in Swiss hospitals: a cross-sectional survey.
Vuichard-Gysin D, Sommerstein R, Kronenberg A, Buetti N, Eder M, Piezzi V, Gardiol C, Schlegel M, Harbarth S, Widmer A. High adherence to national IPC guidelines as key to sustainable VRE control in Swiss hospitals: a cross-sectional survey. Antimicrob Resist Infect Control 2022; 11:19.
28.01.2022High adherence to national IPC guidelines as key to sustainable VRE control in Swiss hospitals: a cross-sectional survey.
28.01.2022Antimicrob Resist Infect Control 2022; 11:19
Vuichard-Gysin Danielle, Sommerstein Rami, Kronenberg Andreas, Buetti Niccolo, Eder Marcus, Piezzi Vanja, Gardiol Céline, Schlegel Matthias, Harbarth Stephan, Widmer Andreas
Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19.
Fröhlich G, van Linde M, Abbas M, Keiser O, Thiabaud A, Roelens M, Cusini A, Flury D, Schreiber P, Buettcher M, Corti N, Vuichard-Gysin D, Troillet N, Sauser J, Gaudenz R, Damonti L, Balmelli C, Iten A, Widmer A, Harbarth S, Sommerstein R. Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19. Euro Surveill 2022; 27
01.01.2022Hospital outcomes of community-acquired COVID-19 versus influenza: Insights from the Swiss hospital-based surveillance of influenza and COVID-19.
01.01.2022Euro Surveill 2022; 27
Fröhlich Georg Marcus, van Linde Myra E, Abbas Mohamed, Keiser Olivia, Thiabaud Amaury, Roelens Maroussia, Cusini Alexia, Flury Domenica, Schreiber Peter W, Buettcher Michael, Corti Natascia, Vuichard-Gysin Danielle, Troillet Nicolas, Sauser Julien, Gaudenz Roman, Damonti Lauro, Balmelli Carlo, Iten Anne, Widmer Andreas F, Harbarth Stephan, Sommerstein Rami
Molecular Epidemiology and Risk Factors for Extended-Spectrum β-Lactamase-Producing Enterobacterales in Long-Term Care Residents
Kohler P, Egli A, Petignat C, Schlegel M, Münzer T, Harbarth S, Gardiol C, Babouee Flury B, Albrich W, Seth-Smith H, Nolte O, Qalla Widmer L, Lemmenmeier E, Rettenmund G, Kessler S, Seiffert S, Héquet D. Molecular Epidemiology and Risk Factors for Extended-Spectrum β-Lactamase-Producing Enterobacterales in Long-Term Care Residents. J Am Med Dir Assoc 2021
21.07.2021Molecular Epidemiology and Risk Factors for Extended-Spectrum β-Lactamase-Producing Enterobacterales in Long-Term Care Residents
21.07.2021J Am Med Dir Assoc 2021
Kohler Philipp, Egli Adrian, Petignat Christiane, Schlegel Matthias, Münzer Thomas, Harbarth Stephan, Gardiol Céline, Babouee Flury Baharak, Albrich Werner, Seth-Smith Helena M B, Nolte Oliver, Qalla Widmer Laetitia, Lemmenmeier Eva, Rettenmund Gabriela, Kessler Simone, Seiffert Salome N, Héquet Delphine
Evaluation of existing and desired measures to monitor, prevent and control healthcare-associated infections in Swiss hospitals
Metsini A, Sommerstein R, Harbarth S, Marschall J, Schlegel M, Maag J, Eder M, Vuichard-Gysin D, Gardiol C, Zingg W, Widmer A, The Swissnoso Network. Evaluation of existing and desired measures to monitor, prevent and control healthcare-associated infections in Swiss hospitals. Swiss Med Wkly 2021; 151:w20516.
14.07.2021Evaluation of existing and desired measures to monitor, prevent and control healthcare-associated infections in Swiss hospitals
14.07.2021Swiss Med Wkly 2021; 151:w20516
Metsini Aliki, Sommerstein Rami, Harbarth Stephan, Marschall Jonas, Schlegel Matthias, Maag Judith, Eder Marcus, Vuichard-Gysin Danielle, Gardiol Céline, Zingg Walter, Widmer Andreas, The Swissnoso Network
Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial
von Dach E, Bochud P, Kaiser L, Harbarth S, Rossel A, McCallin S, Lemmenmeier E, Kohler P, Huttner B, Gayet-Ageron A, Flury D, Cuvelier C, Prendki V, Brunel A, Albrich W, Huttner A. Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial. JAMA 2020; 323:2160-2169.
02.06.2020Effect of C-Reactive Protein-Guided Antibiotic Treatment Duration, 7-Day Treatment, or 14-Day Treatment on 30-Day Clinical Failure Rate in Patients With Uncomplicated Gram-Negative Bacteremia: A Randomized Clinical Trial
02.06.2020JAMA 2020; 323:2160-2169
von Dach Elodie, Bochud Pierre-Yves, Kaiser Laurent, Harbarth Stephan, Rossel Anne, McCallin Shawna, Lemmenmeier Eva, Kohler Philipp, Huttner Benedikt, Gayet-Ageron Angèle, Flury Domenica, Cuvelier Clémence, Prendki Virginie, Brunel Anne-Sophie, Albrich Werner, Huttner Angela
Antibiotic resistance in Swiss nursing homes: analysis of National Surveillance Data over an 11-year period between 2007 and 2017
Kohler P, Schlegel M, Petignat C, Kuster S, Kahlert C, Héquet D, Harbarth S, Balmelli C, Egli A, Albrich W, Fulchini R, Kronenberg A. Antibiotic resistance in Swiss nursing homes: analysis of National Surveillance Data over an 11-year period between 2007 and 2017. Antimicrob Resist Infect Control 2018; 7:88.
20.07.2018Antibiotic resistance in Swiss nursing homes: analysis of National Surveillance Data over an 11-year period between 2007 and 2017
20.07.2018Antimicrob Resist Infect Control 2018; 7:88
Kohler Philipp, Schlegel Matthias, Petignat Christiane, Kuster Stefan, Kahlert Christian, Héquet Delphine, Harbarth Stephan, Balmelli Carlo, Egli Adrian, Albrich Werner, Fulchini Rosamaria, Kronenberg Andreas
PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia
Huttner A, Albrich W, Bochud P, Gayet-Ageron A, Rossel A, Dach E, Harbarth S, Kaiser L. PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia. BMJ Open 2017; 7:e017996.
13.07.2017PIRATE project: point-of-care, informatics-based randomised controlled trial for decreasing overuse of antibiotic therapy in Gram-negative bacteraemia
13.07.2017BMJ Open 2017; 7:e017996
Huttner Angela, Albrich Werner, Bochud Pierre-Yves, Gayet-Ageron Angèle, Rossel Anne, Dach Elodie von, Harbarth Stephan, Kaiser Laurent
Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial
Huttner A, Bernasconi E, Viereck V, Kavvadias T, Kling K, Ryu G, Hülder T, Gröger S, Scheiner D, Alaimo C, Harbarth S, Poolman J, Kuhn A, de Vallière S, Hatz C, van den Dobbelsteen G, Abbanat D, Hornacek A, Frölich R, Dreyer A, Martin P, Davies T, Fae K, van den Nieuwenhof I, Thoelen S, Fonck V. Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial. Lancet Infect Dis 2017; 17:528-537.
24.02.2017Safety, immunogenicity, and preliminary clinical efficacy of a vaccine against extraintestinal pathogenic Escherichia coli in women with a history of recurrent urinary tract infection: a randomised, single-blind, placebo-controlled phase 1b trial
24.02.2017Lancet Infect Dis 2017; 17:528-537
Huttner Angela, Bernasconi Enos, Viereck Volker, Kavvadias Tilemachos, Kling Kerstin, Ryu Gloria, Hülder Tanja, Gröger Sabine, Scheiner David, Alaimo Cristina, Harbarth Stephan, Poolman Jan, Kuhn Anette, de Vallière Serge, Hatz Christoph, van den Dobbelsteen Germie, Abbanat Darren, Hornacek Alena, Frölich Rahel, Dreyer Anita M, Martin Patricia, Davies Todd, Fae Kellen, van den Nieuwenhof Ingrid, Thoelen Stefan, Fonck Veronica Gambillara
Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014
Olearo F, Albrich W, Vernaz N, Harbarth S, Kronenberg A. Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014. Swiss Med Wkly 2016; 146:w14339.
15.09.2016Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014
15.09.2016Swiss Med Wkly 2016; 146:w14339
Olearo Flaminia, Albrich Werner, Vernaz Nathalie, Harbarth Stephan, Kronenberg Andreas
Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting
Albrich W, Harbarth S. Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting. Intensive Care Med 2015
21.07.2015Pros and cons of using biomarkers versus clinical decisions in start and stop decisions for antibiotics in the critical care setting
21.07.2015Intensive Care Med 2015
Albrich Werner, Harbarth Stephan